enGene Therapeutics Inc. (ENGN): SC 13D/A filed Nov 1, 2024

Form type

SC 13D/A

Filing date

Nov 1, 2024

Accession number

0001193125-24-249815

Filer

enGene Therapeutics Inc. (CIK 1980845)